Table 1. Echocardiographic measurements in mice treated with saline, Ang II, or moricizine cotreated.
| Item | Saline | Ang II | Ang II + moricizine | P value |
|---|---|---|---|---|
| LVESD (mm) | 2.28±0.19 | 2.70±0.18 | 4.42±0.16 | 0.243 |
| LVEDD (mm) | 3.67±0.14 | 3.84±0.20 | 3.72±0.18 | 0.781 |
| LVESV (µL) | 19.47±3.72 | 28.62±4.12 | 21.84±2.94 | 0.201 |
| LVEDV (µL) | 58.24±5.08 | 65.87±7.21 | 60.89±5.71 | 0.670 |
| Stroke volume (µL) | 38.77±2.48 | 37.25±4.21 | 39.06±3.47 | 0.924 |
| EF % | 68.65±3.99 | 57.13±3.38 | 65.23±1.96 | 0.065 |
| FS % | 38.57±2.35 | 29.87±2.02 | 35.45±1.96 | 0.066 |
| CO (mL/min) | 19.76±1.36 | 14.79±2.30 | 16.04±2.31 | 0.296 |
| LAD (mm) | 1.80±0.07 | 2.26±0.13 | 1.87±0.01 | 0.004 |
Data are presented means ± SEM; n=9 mice. LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter; LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume; EF, ejection fraction; FS, fractional shortening; CO, cardiac output; LAD, left atrial diameter; SEM, standard error of mean.